Infusion Pump Global MedCore

Implantable Port Market Size, Share, and Trends Analysis | Global | 2024-2030 | MedCore | Includes: Non-Power-Injectable and Power-Injectable Implantable Ports

  • Year: 2024
  • Scope: 10 Years
  • Region: Global
  • Published Date: 10/25/2023
  • Type: MedCore

Product Description

Overall, the global implantable port market was valued slightly over $370 million in 2023. This is expected to increase over the forecast period at a CAGR of 2.8% to reach about $450 million.

Throughout this medical market research, we analyzed over 15 implantable port companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for implantable ports includes non-power-injectable and power-injectable implantable ports.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2030, and Historical Data to 2020
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Global Implantable Port Market Insights

global implantable port market

New technologies are expected to boost the implantable port market, with a growing interest in peripheral placement for site-specific cancer treatment. Although implantable ports exhibit the lowest infection rate among vascular access devices, timely diagnosis and patient immunity remain crucial factors. Ongoing and future advancements are prioritizing reducing infection rates by applying antimicrobial coatings to catheters, enhancing the appeal of ports and fostering competition with PICCs and CVCs.

Global Implantable Port Market Share Insights

global implantable port market

  • In 2023, Becton Dickinson led the implantable port market with the versatile PowerPort® line, including options like the titanium PowerPort® Slim and the lightweight PowerPort® MRI®. They also offered non-power-injectable alternatives like the SlimPort™ Dual-Lumen Rosenblatt™ and the X-Port™.
  • In 2023, AngioDynamics made headway in the implantable port market with innovative products such as Smart Port CT™ featuring integrated Vortex® technology. While the BioFlo® technology succeeded in preventing thrombus formation, the discontinuation of Morpheus® PICC had a more significant impact on PICC sales.
  • In 2023, ICU Medical held the third spot among implantable port market competitors. They were known for the PORT-A-CATH® brand, particularly the MRI-safe PORT-A-CATH II® model. Additionally, they provided hybrid P. A. S. PORT® arm series options. However, the adoption of arm ports was limited due to concerns about catheter pinching due to patient movement.

Market Segmentation Summary

  • Non-Power-Injectable Implantable Port Market
  • Power-Injectable Implantable Port Market

Global Research Scope Summary

Report Attribute Details
Regions North America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year 2023
Forecast 2024-2030
Historical Data 2020-2023
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

 

FREE Sample Report

6.1 Executive Summary
6.1.1 Global Implantable Port Market Overview
6.1.2 Competitive Analysis
6.1.3 Procedures Included
6.1.4 Markets Included
6.1.5 Regions Included
6.2 Introduction
6.3 Procedure Numbers
6.3.1 Total Implantable Port Procedures
6.3.1.1 Power-Injectable Procedures
6.3.1.2 Non-Power-Injectable Procedures
6.4 Market Overview
6.4.1 By Segment
6.4.2 By Region
6.5 Market Analysis and Forecast
6.5.1 Total Implantable Port Market
6.5.2 Power-Injectable Implantable Port Market
6.5.3 Non-Power-Injectable Implantable Port Market
6.6 Drivers and Limiters
6.6.1 Market Drivers
6.6.2 Market Limiters
6.7 Competitive Market Share Analysis
Becton Dickinson
AngioDynamics
ICU Medical
B. Braun
Medcomp
Vygon
PFM Medical
Fresenius
Baxter International
Districlass Medical
Medtronic
V-Tech
Others
Chart 6‑1: Implantable Port Market, Global, 2023 & 2030
Chart 6‑2: Implantable Port Procedures, Global, 2023
Chart 6‑3: Implantable Port Procedures by Region, Global, 2020 – 2030
Chart 6‑4: Implantable Port Market by Segment, Global, 2020 – 2030
Chart 6‑5: Implantable Port Market by Region, Global, 2020 – 2030
Chart 6‑6: Leading Competitors, Implantable Port Market, Global, 2023
Figure 6‑1: Implantable Port Procedures Covered
Figure 6‑2: Implantable Port Markets Covered
Figure 6‑3: Implantable Port Regions Covered, Global (1 of 2)
Figure 6‑4: Implantable Port Regions Covered, Global (2 of 2)
Figure 6‑5: Implantable Port Procedures by Region, Global, 2020 – 2030
Figure 6‑6: Implantable Port Procedures by Country, North America, 2020 – 2030
Figure 6‑7: Implantable Port Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑8: Implantable Port Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑9: Implantable Port Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑10: Implantable Port Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑11: Implantable Port Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑12: Implantable Port Procedures by Country, Middle East, 2020 – 2030
Figure 6‑13: Implantable Port Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑14: Implantable Port Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑15: Implantable Port Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑16: Implantable Port Procedures by Country, Africa, 2020 – 2030
Figure 6‑17: Power-Injectable Procedures by Region, Global, 2020 – 2030
Figure 6‑18: Power-Injectable Procedures by Country, North America, 2020 – 2030
Figure 6‑19: Power-Injectable Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑20: Power-Injectable Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑21: Power-Injectable Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑22: Power-Injectable Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑23: Power-Injectable Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑24: Power-Injectable Procedures by Country, Middle East, 2020 – 2030
Figure 6‑25: Power-Injectable Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑26: Power-Injectable Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑27: Power-Injectable Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑28: Power-Injectable Procedures by Country, Africa, 2020 – 2030
Figure 6‑29: Non-Power-Injectable Procedures by Region, Global, 2020 – 2030
Figure 6‑30: Non-Power-Injectable Procedures by Country, North America, 2020 – 2030
Figure 6‑31: Non-Power-Injectable Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑32: Non-Power-Injectable Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑33: Non-Power-Injectable Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑34: Non-Power-Injectable Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑35: Non-Power-Injectable Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑36: Non-Power-Injectable Procedures by Country, Middle East, 2020 – 2030
Figure 6‑37: Non-Power-Injectable Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑38: Non-Power-Injectable Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑39: Non-Power-Injectable Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑40: Non-Power-Injectable Procedures by Country, Africa, 2020 – 2030
Figure 6‑41: Implantable Port Market by Segment, Global, 2020 – 2030 (US$M)
Figure 6‑42: Implantable Port Market by Region, Global, 2020 – 2030 (US$M)
Figure 6‑43: Implantable Port Market, Global, 2020 – 2030
Figure 6‑44: Units Sold by Region, Implantable Port Market, Global, 2020 – 2030
Figure 6‑45: Average Selling Price by Region, Implantable Port Market, Global, 2020 – 2030 (US$)
Figure 6‑46: Market Value by Region, Implantable Port Market, Global, 2020 – 2030 (US$M)
Figure 6‑47: Power-Injectable Implantable Port Market, Global, 2020 – 2030
Figure 6‑48: Units Sold by Region, Power-Injectable Implantable Port Market, Global, 2020 – 2030
Figure 6‑49: Average Selling Price by Region, Power-Injectable Implantable Port Market, Global, 2020 – 2030 (US$)
Figure 6‑50: Market Value by Region, Power-Injectable Implantable Port Market, Global, 2020 – 2030 (US$M)
Figure 6‑51: Non-Power-Injectable Implantable Port Market, Global, 2020 – 2030
Figure 6‑52: Units Sold by Region, Non-Power-Injectable Implantable Port Market, Global, 2020 – 2030
Figure 6‑53: Average Selling Price by Region, Non-Power-Injectable Implantable Port Market, Global, 2020 – 2030 (US$)
Figure 6‑54: Market Value by Region, Non-Power-Injectable Implantable Port Market, Global, 2020 – 2030 (US$M)
Figure 6‑55: Leading Competitors, Implantable Port Market, Global, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

Overall, the global implantable port market was valued slightly over $370 million in 2023. This is expected to increase over the forecast period at a CAGR of 2.8% to reach about $450 million.

  • 2024
  • 10 Years
  • Global
  • MedCore
  • 10/25/2023
SKU: iDATA_GLVA24_MC_IP Categories: , , , , , , , , , , , , , , , , , , ,
Request Sample Sheets Request Customization
Related Reports
+

REQUEST SAMPLE SHEETS

+

REQUEST CUSTOMIZATION

+

Free Sample Report Form

+

See Report Summary

0
    0
    Your Cart
    Your cart is emptyReturn to Report Library